… Clozapine rechallenge was trialled due to poor response to the ongoing antipsychotic treat…
Changing the focus of the occupational therapy interventions, paused the interventions that …

… Once treatment for NMS is completed, consideration of rechallenge with an antipsychotic
drug is important since many psychiatric patients require dopamine-blocking agents to …

… Background Antipsychotics potentially cause a low incidence of the side effect called
neuroleptic malignant syndrome (NMS), which has a high mortality rate. However, few studies on …

… treatment in this population. To the best of our knowledge, the incidence of neuroleptic
malignant syndrome (NMS) as an adverse effect of antipsychotic use in patients with this disorder …

… taking antipsychotics. Patients with NMS are often forced to rechallenge antipsychotic … NMS
is a potentially fatal condition and we should focus on preventing recurrence of NMS. Further …

… and treating Neuroleptic Malignant Syndrome from the initial management such as the
immediate termination of Neuroleptic Malignant Syndrome … with Neuroleptic Malignant Syndrome …

… Neuroleptic malignant syndrome is more common in males than females, and most
cases … Neuroleptic malignant syndrome: a focus on risk, recognition and antipsychotic rechallenge. …

… nor observational study focusing on this topic, as the literature about antipsychotics in
dementia focuses on the risk of mortality and cerebrovascular events (Rogowska et al., 2023). …

… neuroleptic malignant syndrome (NMS) is typically a complication of treatment with neuroleptic
… of L-dopa or dopamine agonists: neuroleptic malignantlike syndrome (NMLS) (sometimes …

… conditions, such as neuroleptic malignant syndrome (NMS), … effects related to neuroleptic
medication rechallenge. The case … , initial treatment focuses upon the elimination of neuroleptic …